story of the week
GPRC5D-Targeted CAR T-Cell Therapy for Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
GPRC5D-Targeted CAR T Cells for Myeloma
N. Engl. J. Med 2022 Sep 29;387(13)1196-1206, S Mailankody, SM Devlin, J Landa, K Nath, C Diamonte, EJ Carstens, D Russo, R Auclair, L Fitzgerald, B Cadzin, X Wang, D Sikder, B Senechal, VP Bermudez, TJ Purdon, K Hosszu, DP McAvoy, T Farzana, E Mead, JA Wilcox, BD Santomasso, GL Shah, UA Shah, N Korde, A Lesokhin, CR Tan, M Hultcrantz, H Hassoun, M Roshal, F Sen, A Dogan, O Landgren, SA Giralt, JH Park, SZ Usmani, I Rivière, RJ Brentjens, EL SmithFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.